MASTALERZ HAROLD,WITTMAN MARK D.,ZIMMERMANN KURT,SAULNIER MARK G.,VELAPARTHI UPENDER,VYAS DOLATRAI M.,ZHANG GUIFEN,JOHNSON WALTER LEWIS,FRENNESSON DAVID B.,SANG XIAOPENG,LIU PEIYING,LANGLEY DAVID R.,MASTALERZ Harold,WITTMAN Mark D.,ZIMMERMANN Kurt,SAULNIER Mark G.,VELAPARTHI Upender,VYAS Dolatrai
申请号：
SI200731488
公开号：
SI2041138T1
申请日:
2007.07.03
申请国别(地区):
SI
年份:
2014
代理人:
摘要：
The invention provides compounds of formula I and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
